Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Provention Bio
Pharma
Sanofi's Provention buy hit with FTC delay
The U.S. antitrust watchdog is taking more time to review the proposed combination of Sanofi and Provention Bio, two diabetes drug developers.
Angus Liu
Apr 11, 2023 11:00am
Sanofi looks to offload consumer business in India
Mar 31, 2023 10:57am
Sanofi back on M&A trail with $2.9B deal for Provention
Mar 13, 2023 9:18am
AGC Biologics tapped to produce long-awaited diabetes drug
Jan 25, 2023 10:33am
FDA signs off on Provention Bio's drug to slow progession of T1D
Nov 18, 2022 10:55am
Provention Bio lays commercial groundwork as FDA decision looms
Oct 6, 2022 3:40pm
